Vivanta Generics Sro Msn Labratories Private competitive analysis

Loading summary...

Explore patent oppositions filed by Vivanta Generics Sro Msn Labratories Private against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISDec 6, 2022

Latest publications and patents of Vivanta Generics Sro Msn Labratories Private New

Explore the latest publications and patents granted to Vivanta Generics Sro Msn Labratories Private, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Vivanta Generics Sro Msn Labratories Private

Discover the latest PTAB cases involving Vivanta Generics Sro Msn Labratories Private, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Vivanta Generics Sro Msn Labratories Private with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VIVANTA GENERICS SRO MSN LABRATORIES PRIVATE1 - - -
NOVARTIS6422 - 21